TPMC had successfully launched two OTC products in KSA; Prokinin® ”Domperidone” & Ezipan® “Hedra Helix & Thymus Vulgare”.
Tabuk is already the market leader in the segment of “other cough sedatives” with its flagship brand Mentex® “Ammonium, Citric Acid, Dextromethorphan, Diphenhydramine, Menthol, Psudoephedrine”. To strengthen the segment sales & position and to capture the growth opportunity for the herbal cough remedies, Tabuk has launched Thymus Vulgare a new herbal cough product under the brand name of Ezipan®.
The overall segment of Expectorants is bustling with over $ 27.7 million in the private market with 9 percent average compound growth and Tabuk is poised to grab a significant share banking on its successful experience in this segment.